Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/13023
- Title:
- Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin
- Universidade Estadual Paulista (UNESP)
- Universidade Federal de São Paulo (UNIFESP)
- 0344-0338
- The aim of this study was to investigate the expression of p53, caspase-3, bcl-2, MIB-1, and PCNA to validate more objective methods to differentiate squamous cell carcinoma and keratoacanthoma, as well as to understand their pathogenesis with accuracy. A total of 52 cases of histopathologically diagnosed keratoacanthoma in the proliferative stage and 56 cases of well-differentiated squamous cell carcinoma were selected in this study. The expression was evaluated by means of immunohistochemistry. Bcl-2 immunoreactivity was weak or absent in the majority of cases, either in squamous cell carcinoma or in keratoacanthoma. PCNA-positive cells did not show differences between two lesions evaluated. on the other hand, MIB-1 was statistically significant (p<0.05) between squamous cell carcinomas and keratoacanthomas. Moreover, p53 and caspase-3 were overexpressed in squamous cell carcinomas. Together, these results suggest that the biological behavior of the well-differentiated squanous cell carcinomas of the skin may be associated with cellular proliferation and/or deregulation of cell death, indicated by increased expression of the MIB-1 and apoptotic proteins p53 and caspase-3, respectively. (C) 2007 Elsevier GrnbH. All rights reserved.
- 1-Jan-2008
- Pathology Research and Practice. Jena: Elsevier Gmbh, Urban & Fischer Verlag, v. 204, n. 2, p. 97-104, 2008.
- 97-104
- Elsevier Gmbh, Urban & Fischer Verlag
- keratoacanthoma
- squamous cell carcinoma
- cell proliferation
- apoptosis
- http://dx.doi.org/10.1016/j.prp.2007.10.005
- Acesso restrito
- outro
- http://repositorio.unesp.br/handle/11449/13023
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.